ICM Asset Management’s Celgene Corp CELG Stock Holding History

ICM Asset Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,290	Closed	-$394K	–	68
2015 Q4	$394K	Buy	3,290 +12	+0.4%	+$1.39K	0.58%	51
2015 Q3	$355K	Sell	3,278 -4,220	-56%	-$524K	0.57%	55
2015 Q2	$868K	Sell	7,498 -481	-6%	-$55K	0.9%	50
2015 Q1	$920K	Sell	7,979 -278	-3%	-$33.2K	1.02%	44
2014 Q4	$924K	Sell	8,257 -67	-0.8%	-$7.07K	0.94%	45
2014 Q3	$789K	Sell	8,324 -534	-6%	-$48.2K	0.85%	47
2014 Q2	$761K	Sell	8,858 -300	-3%	-$22.8K	0.72%	52
2014 Q1	$639K	Buy	9,158 +924	+11%	+$73.2K	0.61%	58
2013 Q4	$696K	Sell	8,234 -50	-0.6%	-$3.96K	0.63%	59
2013 Q3	$638K	Sell	8,284 -6,354	-43%	-$445K	0.69%	58
2013 Q2	$856K	Buy	+14,638	New	+$881K	0.98%	47

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

ICM Asset Management's CELG Position: Q1 2016 in Review

ICM Asset Management sold out of Celgene Corp (CELG) in Q1 2016, closing a stake of 3,290 shares — an estimated $394K sold.

ICM Asset Management first reported a position in CELG in Q2 2013 and held it in 11 quarters. The position peaked at $924K in Q4 2014. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

ICM Asset Management reported no remaining Celgene Corp position as of Q1 2016 after selling out during the quarter.
ICM Asset Management sold 3,290 Celgene Corp shares in Q1 2016, an estimated $394K.
ICM Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 11 quarters.
ICM Asset Management's Celgene Corp position peaked at $924K in Q4 2014.
1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on ICM Asset Management's 13F filing for Q1 2016, filed 2 May 2016.